Crooke's Changes In Cushing's Syndrome Depends on Degree of Hypercortisolism and Individual Susceptibility

J Clin Endocrinol Metab. 2015 Aug;100(8):3165-71. doi: 10.1210/JC.2015-2493. Epub 2015 Jul 6.

Abstract

Context: Although Crooke's changes in the pituitary corticotrophs were initially described in 1935, the prevalence in which the changes occur in patients with Cushing's syndrome (CS) has not been established.

Objective: This study aimed to determine the prevalence and assess clinical features associated with the presence or absence of Crooke's changes in a large set of patients with CS.

Design: Information from a prospective computer database and retrospective chart review was analyzed.

Setting: The setting was an academic medical center.

Patients: Consecutive patients (N = 213) who received surgery with a preoperative diagnosis of Cushing's disease are included.

Intervention: The patients received pituitary surgery and specimens obtained underwent pathological analysis.

Main outcome measure: The presence or absence of Crooke's changes was determined by histopathological analysis of the normal pituitary tissue included with the specimen obtained at surgery. Cortisol production was measured by 24-hour urine cortisol production.

Results: Crooke's changes occurred in 144 of 177 patients (81%) with a histologically demonstrated ACTH-staining tumor and in 74% of 213 patients diagnosed with CS who had pituitary surgery. The presence of Crooke's changes correlated with the finding of an ACTH-staining tumor removed at surgery and with the degree of hypercortisolism. Among patients with histologically established ACTH-staining tumors the prevalence of Crooke's changes was particularly high in patients with a 24-h urinary free cortisol (UFC) of at least 4-fold the upper limit of normal, in which 91% of patients had Crooke's changes, compared with 74% of patients whose maximum UFC was less than 4-fold the upper limit of normal (P = .008).

Conclusions: Crooke's changes occur in 75-80% of patients with CS, and depend on the degree of hypercortisolism and individual variability. Almost all patients with UFC at least 4-fold the upper limit of normal have them, whereas with less severe hypercortisolism the expression of Crooke's changes varies from person to person.

MeSH terms

  • Adenoma / epidemiology
  • Adenoma / metabolism
  • Adenoma / pathology
  • Adenoma / surgery
  • Adrenocorticotropic Hormone / metabolism
  • Corticotrophs / metabolism
  • Corticotrophs / pathology*
  • Cushing Syndrome / epidemiology*
  • Cushing Syndrome / metabolism
  • Cushing Syndrome / pathology*
  • Cushing Syndrome / surgery
  • Disease Progression
  • Disease Susceptibility* / epidemiology
  • Disease Susceptibility* / pathology
  • Humans
  • Hydrocortisone / metabolism
  • Individuality
  • Pituitary ACTH Hypersecretion / epidemiology*
  • Pituitary ACTH Hypersecretion / metabolism
  • Pituitary ACTH Hypersecretion / pathology*
  • Pituitary ACTH Hypersecretion / surgery
  • Pituitary Gland / metabolism
  • Pituitary Gland / pathology
  • Pituitary Gland / surgery
  • Pituitary Neoplasms / epidemiology
  • Pituitary Neoplasms / metabolism
  • Pituitary Neoplasms / pathology
  • Pituitary Neoplasms / surgery
  • Prevalence
  • Retrospective Studies

Substances

  • Adrenocorticotropic Hormone
  • Hydrocortisone